JP2005506324A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506324A5
JP2005506324A5 JP2003524985A JP2003524985A JP2005506324A5 JP 2005506324 A5 JP2005506324 A5 JP 2005506324A5 JP 2003524985 A JP2003524985 A JP 2003524985A JP 2003524985 A JP2003524985 A JP 2003524985A JP 2005506324 A5 JP2005506324 A5 JP 2005506324A5
Authority
JP
Japan
Prior art keywords
disease
compound according
specifically
formula
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003524985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506324A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/009505 external-priority patent/WO2003020715A1/en
Publication of JP2005506324A publication Critical patent/JP2005506324A/ja
Publication of JP2005506324A5 publication Critical patent/JP2005506324A5/ja
Pending legal-status Critical Current

Links

JP2003524985A 2001-08-30 2002-08-26 抗炎症剤としてのアミノピロール化合物 Pending JP2005506324A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31616901P 2001-08-30 2001-08-30
PCT/EP2002/009505 WO2003020715A1 (en) 2001-08-30 2002-08-26 Aminopyrrole compounds as antiinflammatory agents

Publications (2)

Publication Number Publication Date
JP2005506324A JP2005506324A (ja) 2005-03-03
JP2005506324A5 true JP2005506324A5 (cg-RX-API-DMAC7.html) 2005-11-17

Family

ID=23227809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003524985A Pending JP2005506324A (ja) 2001-08-30 2002-08-26 抗炎症剤としてのアミノピロール化合物

Country Status (16)

Country Link
US (1) US6696471B2 (cg-RX-API-DMAC7.html)
EP (1) EP1423378B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005506324A (cg-RX-API-DMAC7.html)
KR (1) KR20040029075A (cg-RX-API-DMAC7.html)
CN (1) CN1281603C (cg-RX-API-DMAC7.html)
AR (1) AR037140A1 (cg-RX-API-DMAC7.html)
AT (1) ATE309239T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002331179B2 (cg-RX-API-DMAC7.html)
BR (1) BR0212077A (cg-RX-API-DMAC7.html)
CA (1) CA2458808A1 (cg-RX-API-DMAC7.html)
DE (1) DE60207273T2 (cg-RX-API-DMAC7.html)
ES (1) ES2252509T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04001810A (cg-RX-API-DMAC7.html)
PL (1) PL373115A1 (cg-RX-API-DMAC7.html)
RU (1) RU2315045C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003020715A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60331367D1 (de) 2002-12-30 2010-04-01 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
WO2006020365A2 (en) * 2004-07-26 2006-02-23 The Regents Of The University Of California Method for prevention or treatment of inflamatory disease
EP2131858A4 (en) * 2007-03-20 2011-11-23 Cadila Pharmaceuticals Ltd P38 INHIBITORS
US20180325947A1 (en) 2015-10-27 2018-11-15 Children's Hospital Medical Center Use of mapk inhibitors to reduce loss of hematopoietic stem cells during ex vivo culture and/or genetic manipulation
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071147A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. INHIBITORS OF KINASE P38 REDUCING EXPRESSION OF DUX4 GENE AND DOWNSTREAM GENES FOR THE TREATMENT OF FSHD

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
EP0912548A1 (en) 1996-07-11 1999-05-06 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
EP0956018A4 (en) * 1996-08-21 2000-01-12 Smithkline Beecham Corp IMIDAZOLE COMPOUNDS, COMPOSITIONS CONTAINING THEM AND THEIR USE
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
PL344004A1 (en) 1998-05-05 2001-09-10 Hoffmann La Roche Pyrazole derivatives as p-38 map kinase inhibitors
AU3859999A (en) * 1998-05-14 1999-11-29 G.D. Searle & Co. 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2002539128A5 (cg-RX-API-DMAC7.html)
JP2010530881A5 (cg-RX-API-DMAC7.html)
JP2008509187A5 (cg-RX-API-DMAC7.html)
RU2006131132A (ru) 1,3,5,-тризамещенные производные 4,5-дигидро-1н-пиразола, обладающие св1-антагонистической активностью
JP2006151984A5 (cg-RX-API-DMAC7.html)
JP2004526788A5 (cg-RX-API-DMAC7.html)
JP2004514663A5 (cg-RX-API-DMAC7.html)
RU2005109913A (ru) Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr
RU2007111758A (ru) Аминопроизводные 7- амино-3-фенилдигидропиримидо [4,5-d] пиримидинонов, их получение и применение в качестве ингибиторов протеинкиназ
JP2005528443A5 (cg-RX-API-DMAC7.html)
JP2005505618A5 (cg-RX-API-DMAC7.html)
JP2005539045A5 (cg-RX-API-DMAC7.html)
JP2004518723A5 (cg-RX-API-DMAC7.html)
JP2006503850A5 (cg-RX-API-DMAC7.html)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2007507494A5 (cg-RX-API-DMAC7.html)
RU2007101685A (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2002527414A5 (cg-RX-API-DMAC7.html)
JPWO2023099623A5 (cg-RX-API-DMAC7.html)
JP2004523478A5 (cg-RX-API-DMAC7.html)
JP2005506324A5 (cg-RX-API-DMAC7.html)
JP2007534743A5 (cg-RX-API-DMAC7.html)
JP2007507474A5 (cg-RX-API-DMAC7.html)
JP2004536079A5 (cg-RX-API-DMAC7.html)